Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1779489011 | Insulin aspart (recombinant human insulin analogue) 100units/ml injection 3ml pre-filled disposable injection device | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2735638019 | Insulin aspart 100units/mL injection solution 3mL prefilled disposable injection device (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2767647019 | Insulin aspart 100units/mL injection solution 3mL prefilled disposable injection device | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2978441000052114 | aspartinsulin (rekombinant human insulinanalog), 100 E/ml, injektionsvätska, förfylld injektionsenhet för engångsbruk 3 ml | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| aspartinsulin (rekombinant human insulinanalog), 100 E/ml, injektionsvätska, förfylld injektionsenhet för engångsbruk 3 ml | Is a | Product containing insulin aspart (medicinal product) | false | Inferred relationship | Some | ||
| aspartinsulin (rekombinant human insulinanalog), 100 E/ml, injektionsvätska, förfylld injektionsenhet för engångsbruk 3 ml | Has active ingredient | Human insulin | false | Inferred relationship | Some | ||
| aspartinsulin (rekombinant human insulinanalog), 100 E/ml, injektionsvätska, förfylld injektionsenhet för engångsbruk 3 ml | Has active ingredient | Pancreatic hormone | false | Inferred relationship | Some | ||
| aspartinsulin (rekombinant human insulinanalog), 100 E/ml, injektionsvätska, förfylld injektionsenhet för engångsbruk 3 ml | Has active ingredient | Insulin aspart | false | Inferred relationship | Some | ||
| aspartinsulin (rekombinant human insulinanalog), 100 E/ml, injektionsvätska, förfylld injektionsenhet för engångsbruk 3 ml | Has active ingredient | kortverkande insulin | false | Inferred relationship | Some | ||
| aspartinsulin (rekombinant human insulinanalog), 100 E/ml, injektionsvätska, förfylld injektionsenhet för engångsbruk 3 ml | Has manufactured dose form | för injektion | false | Inferred relationship | Some | ||
| aspartinsulin (rekombinant human insulinanalog), 100 E/ml, injektionsvätska, förfylld injektionsenhet för engångsbruk 3 ml | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| aspartinsulin (rekombinant human insulinanalog), 100 E/ml, injektionsvätska, förfylld injektionsenhet för engångsbruk 3 ml | Has manufactured dose form | Solution for injection | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR